サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1455804

FOS（フラクトオリゴ糖）シロップの世界市場-2024-2031年

Global FoS-Oligo Syrup Market - 2024-2031

出版日
ページ情報
英文 209 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
FOS（フラクトオリゴ糖）シロップの世界市場-2024-2031年
出版日: 2024年03月26日
発行: DataM Intelligence
ページ情報: 英文 209 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

FOS（フラクトオリゴ糖）シロップの世界市場は、2023年に4億1,220万米ドルに達し、2031年には6億9,301万米ドルに達し、予測期間2024年にはCAGR 6.7%で成長すると予測されています。

FOSシロップの需要は、腸内健康の価値とプレバイオティクスが一般的な健康をサポートする上で果たす役割に対する消費者の意識の高まりによって牽引されています。顧客は、単純な栄養補給にとどまらず、さらなる健康上の利点を提供する有用成分を含む商品を求めています。砂糖の過剰摂取による健康被害への懸念が高まる中、自然で健康的な甘味料オプションを求める動きがあります。

FOSシロップは、植物から作られた天然甘味料として、通常の砂糖のよりクリーンな代替品になると考えられています。ScienceDirectのデータによると、米国の最近の全国栄養調査では、子供の約25％、成人の41％以上が低カロリー甘味料（LCS）を含む食品・飲料を摂取していると報告されています。この数字は、1999年から2022年までで、子供のLCS消費量が200％、大人のLCS消費量が54％急増したことを表しています。

FOSシロップ市場では、食品・飲料分野がシェアの3分の1以上を占めています。同様に、欧州がFOSシロップ市場を独占し、1/3以上の最大市場シェアを獲得しています。消費者が健康とウェルネスを優先し、同地域の幅広い食品・飲料製品にプレバイオティクス成分を組み込むことを促進するため、欧州におけるFOSシロップの需要は引き続き拡大すると予想されます。

ダイナミクス

生活習慣に関連した健康問題の有病率の上昇

FOSシロップ市場は、実際、ライフスタイルの選択に関連する健康問題の有病率の上昇によって大きく牽引されています。肥満、糖尿病、胃腸疾患のような生活習慣に関連した健康問題の蔓延は、FOSシロップのような機能性食品成分や、より良い食品の選択肢に対する消費者の需要を高めています。

世界的に、特に肥満の割合は著しく上昇しています。世界肥満アトラス（World Obesity Atlas）の2023年版報告書によると、世界の過体重と肥満（BMI >=25kg/m2）（アトラス全体では高BMIとも呼ばれる）のレベルは、2020年には26億人以上であったのに対し、2035年には40億人以上が罹患する可能性があります。これは、2020年の世界人口の38％から、2035年には50％以上に増加することを反映しています（数字は5歳未満の子どもを除く）。

肥満（BMI >=30kg/m2）の有病率だけでも、同じ期間に人口の14%から24%に増加し、2035年までに20億人近くの成人、小児、青年が影響を受けると予測されています。肥満が心臓病、2型糖尿病、一部の悪性腫瘍など多くの慢性疾患の重大な危険因子であることを考えると、このような事態は懸念すべきものです。

このような健康動向を受けて、消費者は健康に対してより積極的になり、基本的な栄養を超えた機能的なメリットを提供する食品や食材を求めるようになっています。FOSシロップは、プレバイオティック成分であるため、消化器系の健康と全体的な健康の促進を目的として販売される様々な食品・飲料への配合が増加しています。

機能性食品への需要の増加

FOSシロップの市場は、実際、機能性食品に対する需要の高まりによって大きく牽引されています。機能性食品として分類される食品は、基本的な栄養に加えて健康と幸福をサポートする生物活性化学物質を含むことが多いです。FOSシロップは、善玉腸内細菌の増殖を促進し、消化器系の健康を増進する能力があるため、プレバイオティクス成分としてこのカテゴリーに当てはまる。

健康志向の高まり、食習慣の変化、栄養と健康の関連性に関する知識の増加はすべて、最近の世界の機能性食品市場の力強い上昇に寄与しています。プレバイオティクス特性を持つFOSシロップは、シリアル、ヨーグルト、食品・飲料、ベーカリー製品などの幅広い機能性食品にますます組み込まれ、栄養プロファイルと健康促進特性を高めています。

規制上の課題と表示要件

表示規制と規制上の障害は、FOSシロップに深刻な市場障害をもたらす可能性があります。特にFOSシロップのような機能性成分に関する表示規制や健康強調表示に関しては、その主目的が消費者の保護と食品の安全性の確保であるにもかかわらず、規制がメーカーにとっての障壁となる可能性があります。

様々な国や地域間で規制要件が統一されていないことが、主な障害の一つとなっています。複数の市場で事業を展開する生産者にとっては、FOSシロップを含む製品の表示と販売に関する異なる規制を遵守しなければならない可能性があるため、これは複雑な結果を招きかねないです。例えば、「プレバイオティクス」や「機能性食品」などの用語は、国によって定義や規制が異なる場合があり、FOSシロップ製品の表示方法に影響を与える可能性があります。

目次

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 生活習慣に関連する健康問題の有病率の上昇
      • 機能性食品への需要の高まり
    • 抑制要因
      • 規制上の課題と表示要件
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 由来別

  • ショ糖由来
  • イヌリン由来
  • その他

第8章 タイプ別

  • 短鎖FOS（scFOS）
  • 中鎖FOS（mcFOS）
  • 長鎖FOS（lcFOS）

第9章 エンドユーザー別

  • 食品・飲料
  • 医薬品
  • 化粧品・パーソナルケア
  • 工業用
  • その他

第10章 流通チャネル別

  • スーパーマーケット/ハイパーマーケット
  • オンライン小売
  • 専門店
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東およびアフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • ADM BENEO GmbH
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Sensus B.V.
  • Tereos S.A.
  • Cosucra Groupe Warcoing S.A.
  • Quantum Hi-Tech（China）Biological Co., Ltd.
  • Baolingbao Biology Co., Ltd.
  • Ningbo J&S Botanics Inc.
  • Cargill, Incorporated
  • Dupont de Nemours, Inc.
  • Ingredion Incorporated

第14章 付録

目次
Product Code: FB8287

Overview

Global FoS-Oligo Syrup Market reached US$ 412.2 million in 2023 and is expected to reach US$ 693.01 million by 2031, growing with a CAGR of 6.7% during the forecast period 2024-2031.

The demand for FoS-Oligo syrup has been driven by rising consumer awareness of the value of gut health and the part prebiotics play in supporting general well-being. Customers are looking for goods with useful ingredients that go beyond simple nourishment to provide additional health advantages. There is a movement toward natural and healthy sweetening options as worries about the health hazards of excessive sugar consumption increase.

As a natural sweetener made from plant materials, FoS-Oligo syrup is thought to be a cleaner-label substitute for regular sugars. According to ScienceDirect data, about 25 percent of children and more than 41 percent of adults in the U.S. reported consuming foods and beverages containing low-calorie sweeteners (LCS) in a recent nationwide nutritional survey. Those numbers represent a 200 percent increase in LCS consumption for children and a 54 percent jump for adults from 1999 to 2022.

The food and beverage segment in FoS-oligo syrup market accounts for over one-third of the share. Similarly, Europe dominates the FoS-oligo syrup market, capturing the largest market share of over 1/3rd. The demand for FoS-Oligo syrup in Europe is expected to continue growing as consumers prioritize health and wellness, driving the incorporation of prebiotic ingredients into a wide range of food and beverage products across the region.

Dynamics

Rise in Prevalence of Lifestyle-Related Health Issues

The market for FoS-Oligo syrup is, in fact, significantly driven by the rise in the prevalence of health problems associated with lifestyle choices. The prevalence of lifestyle-related health problems like obesity, diabetes, and gastrointestinal diseases has increased consumer demand for functional food components like FoS-Oligo syrup and better food options.

Globally, rates of obesity in particular have been rising significantly. World Obesity Atlas report of 2023 estimates for global levels of overweight and obesity (BMI >=25kg/m2), also referred to as high BMI throughout the Atlas, suggest that over 4 billion people may be affected by 2035, compared with over 2.6 billion in 2020. This reflects an increase from 38% of the world's population in 2020 to over 50% by 2035 (figures exclude children under 5 years old).

The prevalence of obesity (BMI >=30kg/m2) alone is anticipated to rise from 14% to 24% of the population over the same period, affecting nearly 2 billion adults, children, and adolescents by 2035. Given that obesity is a significant risk factor for many chronic illnesses, such as heart disease, type 2 diabetes, and some malignancies, this development is concerning.

In response to these concerning health trends, consumers are becoming more proactive about their health and are seeking out foods and ingredients that offer functional benefits beyond basic nutrition. FoS-Oligo syrup, being a prebiotic ingredient, is increasingly being incorporated into various food and beverage products marketed toward promoting digestive health and overall well-being.

Increasing Demand for Functional Foods

The market for FoS-Oligo syrup is, in fact, significantly driven by the rising demand for functional foods. Foods classified as functional often contain bioactive chemicals that support health and well-being in addition to basic nourishment. FoS-Oligo syrup fits into this category as a prebiotic component because of its capacity to promote the growth of good gut bacteria and enhance digestive health.

The increased health consciousness, shifting dietary habits, and increased knowledge of the connection between nutrition and health have all contributed to the recent strong rise of the worldwide functional food market. FoS-Oligo syrup, with its prebiotic properties, is increasingly being incorporated into a wide range of functional food products such as cereals, yogurt, beverages, and bakery items to enhance their nutritional profile and health-promoting properties.

Regulatory Challenges and Labeling Requirements

Labeling regulations and regulatory obstacles may pose serious market obstacles for FoS-oligo syrup. Regulations can be a barrier for manufacturers, especially when it comes to labeling regulations and health claims related to functional ingredients like FoS-Oligo syrup, even while its main goal is to protect consumers and assure food safety.

The absence of uniformity in regulatory requirements among various nations and areas is one of the main obstacles. For producers who operate in several markets, this can result in complications because they may have to adhere to different regulatory regulations governing the labeling and marketing of products that include FoS-Oligo syrup. Terms like "prebiotic" and "functional food," for instance, may be defined and regulated differently in different countries, which may affect how FoS-Oligo syrup products are labeled.

Segment Analysis

The global FoS-oligo syrup market is segmented based on origin, type, end-user, distribution channel and region.

The Surging Demand for Functional Ingredients in the Global Market

Some factors affect the market for FoS-Oligo syrup made from sucrose, but the main one is consumer preferences for natural and healthier sweeteners. Fos-oligo syrup made from sucrose is a naturally occurring source of fructo-oligosaccharides (FOS), which are produced by the enzymatic hydrolysis of sucrose and provide both sweetness and prebiotic advantages.

Manufacturers are also striving to produce the natural sweeteners to attract the consumers. In April 2021, Manus Bio, Inc. (Manus Bio), a leading U.S. manufacturer of sustainable natural ingredients, announced the launch of NutraSweet Natural, a plant-based sweetener with zero calories and 100% pure-tasting sweetness to enjoy in daily life. Manus Bio is paving the way for next-generation calorie reduction with a unique green technology for sourcing nature's sweetest ingredients while minimizing its environmental footprint.

The growing consumer awareness and worry about the harmful health implications of excessive sugar consumption, such as obesity, diabetes, and dental problems, is one important factor driving demand. Consequently, there is a growing movement to cut back on sugar consumption and look for better sweetener options. FoS-Oligo syrup, which is formed from sucrose, is a good option for producers who want to create goods with less sugar while keeping them sweet and useful.

Geographical Penetration

Increasing Trend of Gut Health and Overall Well-being among Europeans

According to UC Health gastroenterologist Hany Al-khedr, digestive diseases affect more than 300 million people in Europe and are linked to substantial economic costs. The incidence and prevalence of CD and UC are increasing in Europe, with an estimated 0.3% of the European population suffering from IBD, equalling 2.5-3 million persons. There is also a strong east/west gradient in the incidence of gastric cancer, which reflects the higher prevalence of H. pylori infection in eastern Europe and parts of southern Europe.

The demand for FoS-oligo syrup in Europe has been steadily increasing over recent years due to several factors. Firstly, there is a growing awareness among European consumers regarding the importance of gut health and the role of prebiotics in promoting it. FoS-oligo syrup, being a prebiotic ingredient, is sought after by health-conscious consumers who are looking for products that support digestive health and overall well-being.

The European market for FoS-Oligo syrup has also expanded as a result of initiatives and regulatory support for the use of prebiotics in food items. To stimulate consumer interest and demand, regulatory bodies like the European Food Safety Authority (EFSA) have approved health claims about the advantages of prebiotics. This gives manufacturers the chance to market products containing FoS-Oligo syrup with specific health claims.

COVID-19 Impact Analysis

The market for FoS-Oligo syrup was greatly influenced by the COVID-19 epidemic in several ways. Initially, difficulties locating raw materials and transporting completed goods were caused by disruptions in the global supply chain and logistics. The implementation of lockdown measures and movement limitations had an impact on customer purchase behavior, resulting in a shift towards essential products and a decrease in discretionary spending on functional food ingredients such as FoS-Oligo syrups.

On the other hand, demand for functional food products-including those with prebiotic components like FoS-Oligo syrups-grew as knowledge of the pandemic's health and immunity-boosting advantages increased. When customers looked for items that promoted gut health and general well-being, this trend-combined with an emphasis on preventative healthcare-stimulated market recovery and growth in some countries.

Russia-Ukraine War Impact Analysis

The conflict between Russia and Ukraine has caused major uncertainty and interruptions in a number of businesses, including the market for FoS-Oligo syrup. Given the importance of both Russia and Ukraine to the world's agriculture, any interruption in the supply chain-such as export limitations or logistical difficulties-may have an effect on where raw materials for the production of FoS-Oligo syrup are sourced.

The cost of producing and distributing FoS-Oligo syrups can also be impacted by changes in import-export laws and currency exchange rates brought on by geopolitical unrest and trade disruptions. Increased geopolitical tensions can also foster a climate of uncertainty that affects consumer and investor attitude and may reduce demand for non-essential food items like FoS-Oligo syrups.

By Origin

  • Sucrose-Derived
  • Inulin-Derived
  • Others

By Type

  • Short-chain FOS (scFOS)
  • Medium-chain FOS (mcFOS)
  • Long-chain FOS (mcFOS)

By End-User

  • Food and Beverage
  • Pharmaceuticals
  • Cosmetics & Personal Care
  • Industrial
  • Others

By Distribution Channel

  • Supermarkets/Hypermarkets
  • Online Retail
  • Specialty Stores
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In June 2022, Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and beverage ingredients and solutions, announced that it has completed the acquisition of Quantum Hi-Tech (Guangdong) Biological Co., Ltd (Quantum), a leading prebiotic dietary fiber business located in China. FOS and GOS fibers are highly complementary to their existing fiber portfolio and will allow offering a broader range of solutions to their customers across key markets.
  • In January 2022, Galam, a global manufacturer of specialty ingredients for the food and animal nutrition industries, launched a production plant for its prebiotic GOFOS. It is a short-chain fructooligosaccharide (sc-FOS) group of strong prebiotics, with scientific evidence suggesting daily consumption can bring about various health benefits in humans and animals. GOFOS is a soluble sc-FOS prebiotic fiber made by Galam.
  • In June 2020, global nutrition ingredients manufacturer Galam invested USD 20 million in the launch of two new fructooligosaccharides (FOS) production plants, each with a capacity to manufacture thousands of tons of the increasingly popular gut health-benefiting prebiotic fibers.

Competitive Landscape

The major global players in the market include BENEO GmbH, Sensus B.V., Tereos S.A., Cosucra Groupe Warcoing S.A., Quantum Hi-Tech (China) Biological Co., Ltd., Baolingbao Biology Co., Ltd., Ningbo J&S Botanics Inc., Cargill, Incorporated, Dupont de Nemours, Inc., and Ingredion Incorporated.

Why Purchase the Report?

  • To visualize the global FoS-oligo syrup market segmentation based on origin, type, end-user, distribution channel, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of FoS-oligo syrup market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global FoS-oligo syrup market report would provide approximately 70 tables, 66 figures, and 209 Pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet By Origin
  • 3.2.Snippet by Type
  • 3.3.Snippet by End-User
  • 3.4.Snippet by Distribution Channel
  • 3.5.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Rise in Prevalence of Lifestyle-Related Health Issues
      • 4.1.1.2.Increasing Demand for Functional Foods
    • 4.1.2.Restraints
      • 4.1.2.1.Regulatory Challenges and Labeling Requirements
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.Russia-Ukraine War Impact Analysis
  • 5.6.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Origin

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
    • 7.1.2.Market Attractiveness Index, By Origin
  • 7.2.Sucrose-Derived*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Inulin-Derived
  • 7.4.Others

8.By Type

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2.Market Attractiveness Index, By Type
  • 8.2.Short-chain FOS (scFOS)*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Medium-chain FOS (mcFOS)
  • 8.4.Long-chain FOS (mcFOS)

9.By End-User

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2.Market Attractiveness Index, By End-User
  • 9.2.Food & Beverage*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Pharmaceuticals
  • 9.4.Cosmetics & Personal Care
  • 9.5.Industrial
  • 9.6.Others

10.By Distribution Channel

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.1.2.Market Attractiveness Index, By Distribution Channel
  • 10.2.Supermarkets/Hypermarkets*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Online Retail
  • 10.4.Specialty Stores
  • 10.5.Others

11.By Region

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2.Market Attractiveness Index, By Region
  • 11.2.North America
    • 11.2.1.Introduction
    • 11.2.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

    • 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1.U.S.
      • 11.2.6.2.Canada
      • 11.2.6.3.Mexico
  • 11.3.Europe
    • 11.3.1.Introduction
    • 11.3.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

    • 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.6.1.Germany
      • 11.3.6.2.UK
      • 11.3.6.3.France
      • 11.3.6.4.Italy
      • 11.3.6.5.Spain
      • 11.3.6.6.Rest of Europe
  • 11.4.South America
    • 11.4.1.Introduction
    • 11.4.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

    • 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.6.1.Brazil
      • 11.4.6.2.Argentina
      • 11.4.6.3.Rest of South America
  • 11.5.Asia-Pacific
    • 11.5.1.Introduction
    • 11.5.2.Key Region-Specific Dynamics
    • 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
    • 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1.China
      • 11.5.7.2.India
      • 11.5.7.3.Japan
      • 11.5.7.4.Australia
      • 11.5.7.5.Rest of Asia-Pacific
  • 11.6.Middle East and Africa
    • 11.6.1.Introduction
    • 11.6.2.Key Region-Specific Dynamics
    • 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
    • 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12.Competitive Landscape

  • 12.1.Competitive Scenario
  • 12.2.Market Positioning/Share Analysis
  • 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

  • 13.1.ADM BENEO GmbH*
    • 13.1.1.Company Overview
    • 13.1.2.Product Portfolio and Description
    • 13.1.3.Financial Overview
    • 13.1.4.Key Developments
  • 13.2.Sensus B.V.
  • 13.3.Tereos S.A.
  • 13.4.Cosucra Groupe Warcoing S.A.
  • 13.5.Quantum Hi-Tech (China) Biological Co., Ltd.
  • 13.6.Baolingbao Biology Co., Ltd.
  • 13.7.Ningbo J&S Botanics Inc.
  • 13.8.Cargill, Incorporated
  • 13.9.Dupont de Nemours, Inc.
  • 13.10.Ingredion Incorporated

LIST NOT EXHAUSTIVE

14.Appendix

  • 14.1.About Us and Services
  • 14.2.Contact Us